Table 1 Baseline demographic and clinical characteristics
CD | UC | |
|---|---|---|
N = 540 | N = 373 | |
Age on index date (years) | ||
Mean (SD) | 36.8 (14.6) | 39.9 (15.2) |
Age categories, n (%) | ||
18–34 | 275 (50.9) | 161 (43.2) |
35–44 | 96 (17.8) | 82 (22.0) |
45–54 | 86 (15.9) | 58 (15.5) |
55–64 | 69 (12.8) | 49 (13.1) |
≥ 65 | 14 (2.6) | 23 (6.2) |
Sex, n (%) | ||
Female | 270 (50.0) | 164 (44.0) |
Residence region, n (%) | ||
Northeast | 88 (16.3) | 62 (16.6) |
Midwest | 160 (29.6) | 104 (27.9) |
South | 192 (35.6) | 122 (32.7) |
West | 94 (17.4) | 84 (22.5) |
Plan type, n (%) | ||
HMO | 141 (26.1) | 79 (21.2) |
PPO | 299 (55.4) | 232 (62.2) |
CDHP | 100 (18.5) | 62 (16.6) |
Other/unknown | 0 (0) | 0 (0) |
Index diagnosis, n (%) | ||
2014 | 142 (26.3) | 103 (27.6) |
2015 | 175 (32.4) | 114 (30.6) |
2016 | 141 (26.1) | 109 (29.2) |
2017 | 82 (15.2) | 47 (12.6) |
Time from index diagnosis to the initiation date of advanced therapies (months) | ||
Mean (SD) | 7.1 (9.1) | 10.9 (11.1) |
Provider specialty on index date, n (%) | ||
Gastroenterologist | 166 (30.7) | 128 (34.3) |
Primary care physician | 35 (6.5) | 28 (7.5) |
Others | 334 (61.9) | 217 (58.2) |
QCI | ||
Mean (SD) | 0.4 (0.8) | 0.5 (1.0) |
Comorbid conditions, n (%) | ||
Peripheral vascular disease | 16 (3.0) | 11 (2.9) |
Chronic pulmonary disease | 61 (11.3) | |
Mild liver disease | 49 (9.1) | |
Diabetes without chronic complication | 24 (4.4) | 32 (8.6) |
Anemia | 183 (33.9) | 134 (35.9) |
Dyslipidemia | 71 (13.1) | 79 (21.2) |
Fibromyalgia | 14 (2.6) | * |
Hypertension | 105 (19.4) | 88 (23.6) |
Mental illness | 201 (37.2) | 118 (31.6) |
Osteoarthritis | 35 (6.5) | 28 (7.5) |
Infections | 291 (53.9) | 207 (55.5) |
Nicotine dependence/tobacco use disorder | 121 (22.4) | 72 (19.3) |